Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alexion Pharmaceuticals, Inc.
Pharmaceuticals firm reports slight decrease in revenues
July 6th, 2005
Alexion Pharmaceuticals, Inc., (ALXN) announced financial results for its third fiscal quarter and 9 months ended April 30, 2005. For the quarter ended April 30, 2005, Alexion reported revenues of $151,000 compared to $168,000 for the same period last year. The slight decrease was attributable to a decrease in research grant revenues. Total operating expenses for the quarter were $29.8 million compared to $14.4 million in the same quarter last year. The company's research and development expenses for the 3-month period ended April 30, 2005, were $25.0 million compared to $10.8 million for the same period last year. The increase in...
Source: Biotech Week (2005-07-06)
|
